INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA

被引:0
|
作者
Antony-Debre, I. [1 ,2 ]
Leite, J. [1 ]
Paul, A. [3 ]
Mitchell, K. [1 ]
Kim, H. M. [3 ]
Huang, K. [3 ]
Kumar, A. [3 ]
Farahat, A. A. [3 ]
Bartholdy, B. [1 ]
Narayanagari, S. -R. [1 ]
Carvajal, L. A. [1 ]
Chen, J. [1 ]
Ambesi-Impiombato, A. [4 ]
Ferrando, A. A. [4 ]
Mantzaris, I. [1 ]
Gavathiotis, E. [1 ]
Verma, A. [1 ]
Will, B. [1 ]
Boykin, D. W. [3 ]
Wilson, W. D. [3 ]
Poon, G. M. K. [3 ]
Steidl, U. [1 ]
机构
[1] Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY USA
[2] Gustave Roussy, Inserm U1170, Villejuif, France
[3] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA
[4] Columbia Univ, Inst Canc Genet, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S135
引用
收藏
页码:18 / 18
页数:1
相关论文
共 50 条
  • [21] Inhibition of Mitochondrial Translation As a Therapeutic Strategy for Acute Myeloid Leukemia (AML)
    Skrtic, Marko
    Sriskanthadevan, Shrivani
    Livak, Bozhena
    Gebbia, Marinella
    Wang, Xiaoming
    Wang, Zezhou
    Hurren, Rose
    Jitkova, Yulia
    Gronda, Marcela
    Maclean, Neil
    Lai, Courteney
    Eberhard, Yanina
    Bartoszko, Justyna
    Spagnuolo, Paul A.
    Rutledge, Angela
    Datti, Alessandro
    Ketela, Troy
    Moffat, Jason
    Robinson, Brian H.
    Cameron, Jessie M.
    Wrana, Jeff L.
    Eaves, Connie J.
    Minden, Mark D.
    Wang, Jean C. Y.
    Dick, John E.
    Humphries, R. Keith
    Nislow, Corey
    Giaever, Guri
    Schimmer, Aaron D.
    BLOOD, 2011, 118 (21) : 106 - 107
  • [22] Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
    Britta Will
    Thomas O Vogler
    Swathi Narayanagari
    Boris Bartholdy
    Tihomira I Todorova
    Mariana da Silva Ferreira
    Jiahao Chen
    Yiting Yu
    Jillian Mayer
    Laura Barreyro
    Luis Carvajal
    Daniela Ben Neriah
    Michael Roth
    Johanna van Oers
    Sonja Schaetzlein
    Christine McMahon
    Winfried Edelmann
    Amit Verma
    Ulrich Steidl
    Nature Medicine, 2015, 21 : 1172 - 1181
  • [23] Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia
    Will, Britta
    Vogler, Thomas O.
    Narayanagari, Swathi
    Bartholdy, Boris
    Todorova, Tihomira I.
    Ferreira, Mariana da Silva
    Chen, Jiahao
    Yu, Yiting
    Mayer, Jillian
    Barreyro, Laura
    Carvajal, Luis
    Ben Neriah, Daniela
    Roth, Michael
    van Oers, Johanna
    Schaetzlein, Sonja
    McMahon, Christine
    Edelmann, Winfried
    Verma, Amit
    Steidl, Ulrich
    NATURE MEDICINE, 2015, 21 (10) : 1172 - +
  • [24] Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia
    Metcalf, D
    Dakic, A
    Mifsud, S
    Di Rago, L
    Wu, L
    Nutt, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1486 - 1491
  • [25] Inhibition of IRAK1 As a Novel Therapeutic Strategy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Rhyasen, Garrett
    Bolanos, Lyndsey
    Fang, Jing
    Rigolino, Carmen
    Cortelezzi, Agostino
    Oliva, Esther Natalie
    Cuzzola, Mariella
    Starczynowski, Daniel T.
    BLOOD, 2011, 118 (21) : 281 - 281
  • [26] Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
    Xi Jiang
    Chao Hu
    Kyle Ferchen
    Ji Nie
    Xiaolong Cui
    Chih-Hong Chen
    Liting Cheng
    Zhixiang Zuo
    William Seibel
    Chunjiang He
    Yixuan Tang
    Jennifer R. Skibbe
    Mark Wunderlich
    William C. Reinhold
    Lei Dong
    Chao Shen
    Stephen Arnovitz
    Bryan Ulrich
    Jiuwei Lu
    Hengyou Weng
    Rui Su
    Huilin Huang
    Yungui Wang
    Chenying Li
    Xi Qin
    James C. Mulloy
    Yi Zheng
    Jiajie Diao
    Jie Jin
    Chong Li
    Paul P. Liu
    Chuan He
    Yuan Chen
    Jianjun Chen
    Nature Communications, 8
  • [27] Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
    Jiang, Xi
    Hu, Chao
    Ferchen, Kyle
    Nie, Ji
    Cui, Xiaolong
    Chen, Chih-Hong
    Cheng, Liting
    Zuo, Zhixiang
    Seibel, William
    He, Chunjiang
    Tang, Yixuan
    Skibbe, Jennifer R.
    Wunderlich, Mark
    Reinhold, William C.
    Dong, Lei
    Shen, Chao
    Arnovitz, Stephen
    Ulrich, Bryan
    Lu, Jiuwei
    Weng, Hengyou
    Su, Rui
    Huang, Huilin
    Wang, Yungui
    Li, Chenying
    Qin, Xi
    Mulloy, James
    Zheng, Yi
    Diao, Jiajie
    Jin, Jie
    Li, Chong
    Liu, Paul P.
    He, Chuan
    Chen, Yuan
    Chen, Jianjun
    NATURE COMMUNICATIONS, 2017, 8
  • [28] Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
    Cole, Alicia
    Wang, Zezhou
    Coyaud, Etienne
    Voisin, Veronique
    Gronda, Marcela
    Jitkova, Yulia
    Mattson, Rachel
    Hurren, Rose
    Babovic, Sonja
    Maclean, Neil
    Restall, Ian
    Wang, Xiaoming
    Jeyaraju, Danny V.
    Sukhai, Mahadeo A.
    Prabha, Swayam
    Bashir, Shaheena
    Ramakrishnan, Ashwin
    Leung, Elisa
    Qia, Yi Hua
    Zhang, Nianxian
    Combes, Kevin R.
    Ketela, Troy
    Lin, Fengshu
    Houry, Walid A.
    Aman, Ahmed
    Al-awar, Rima
    Zheng, Wei
    Wienholds, Erno
    Xu, Chang Jiang
    Dick, John
    Wang, Jean C. Y.
    Moffat, Jason
    Minden, Mark D.
    Eaves, Connie J.
    Bader, Gary D.
    Hao, Zhenyue
    Kornblau, Steven M.
    Raught, Brian
    Schimmer, Aaron D.
    CANCER CELL, 2015, 27 (06) : 864 - 876
  • [29] PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
    Curtiss, Brittany M.
    VanCampen, Jake
    Macaraeg, Jommel
    Kong, Garth L.
    Taherinasab, Akram
    Tsuchiya, Mitsuhiro
    Yashar, William M.
    Tsang, Yiu H.
    Horton, Wesley
    Coleman, Daniel J.
    Estabrook, Joseph
    Lusardi, Theresa A.
    Mills, Gordon B.
    Druker, Brian J.
    Maxson, Julia E.
    Braun, Theodore P.
    LEUKEMIA, 2022, 36 (07) : 1781 - 1793
  • [30] PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia
    Brittany M. Curtiss
    Jake VanCampen
    Jommel Macaraeg
    Garth L. Kong
    Akram Taherinasab
    Mitsuhiro Tsuchiya
    William M. Yashar
    Yiu H. Tsang
    Wesley Horton
    Daniel J. Coleman
    Joseph Estabrook
    Theresa A. Lusardi
    Gordon B. Mills
    Brian J. Druker
    Julia E. Maxson
    Theodore P. Braun
    Leukemia, 2022, 36 : 1781 - 1793